NeuroSense Therapeutics For Profit
NeuroSense Therapeutics New Hope on The Horizon Our Research Intro to NeuroSense Therapeutics About NeuroSense NeuroSense was born with the intent to answer the huge unmet need of patients with amyotrophic lateral sclerosis (ALS) with the understanding that this devastating disease must be addressed from a new perspective. NeuroSense Therapeutics is a clinical-stage drug development […]
Founded Date:
2017-01-01
Headquarters:
Herzliya, Tel Aviv, Israel
Technology:
Biomarker panels
Employee Number:
11-50
Industry:
Clinical Data Management
Estimated Revenue:
Less than $1M